Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVB
1601
CALL
DELISTED
AvalonBay Communities
AVB
| $8.89M | ﹤0.01% |
50,000
+21,900
| +78% | +$3.94M |
|
1602
PUT
Dominion Energy
D
$58.8B
| $8.85M | ﹤0.01% |
119,100
+57,300
| +93% | +$4.37M |
|
1603
PUT
Ross Stores
ROST
$75.8B
| $8.84M | ﹤0.01% |
137,400
+24,800
| +22% | +$1.52M |
|
|
NS
1604
CALL
DELISTED
NuStar Energy L.P.
NS
| $8.84M | ﹤0.01% |
178,200
-101,900
| -36% | -$4.91M |
|
1605
PUT
Vanguard S&P 500 ETF
VOO
$1.02T
| $8.82M | ﹤0.01% |
44,400
-11,900
| -21% | -$2.36M |
|
1606
PUT
Alamos Gold
AGI
$15.7B
| $8.78M | ﹤0.01% |
1,070,500
+34,300
| +3% | +$299K |
|
|
CEQP
1607
CALL
DELISTED
Crestwood Equity Partners LP
CEQP
| $8.78M | ﹤0.01% |
413,100
-45,200
| -10% | -$943K |
|
1608
CALL
ProShares Ultra Silver
AGQ
$1.6B
| $8.77M | ﹤0.01% |
182,200
-84,600
| -32% | -$4.31M |
|
1609
PUT
NRG Energy
NRG
$24.4B
| $8.77M | ﹤0.01% |
781,900
-109,500
| -12% | -$1.43M |
|
|
LCI
1610
PUT
DELISTED
Lannett Company, Inc.
LCI
| $8.77M | ﹤0.01% |
82,475
+16,200
| +24% | +$1.98M |
|
1611
SPX Corp
SPXC
$10.3B
| $8.76M | ﹤0.01% |
434,928
| – | – |
|
1612
CALL
Veeva Systems
VEEV
$39.7B
| $8.76M | ﹤0.01% |
212,100
-30,700
| -13% | -$1.19M |
|
1613
CALL
TC Energy
TRP
$65.5B
| $8.75M | ﹤0.01% |
184,000
-79,300
| -30% | -$3.7M |
|
|
MDCO
1614
DELISTED
Medicines Co
MDCO
| $8.74M | ﹤0.01% |
231,712
+171,052
| +282% | +$6.45M |
|
1615
PUT
Idacorp
IDA
$7.99B
| $8.74M | ﹤0.01% |
+111,700
| New | +$8.81M |
|
1616
CALL
Agios Pharmaceuticals
AGIO
$2.03B
| $8.73M | ﹤0.01% |
165,300
+87,600
| +113% | +$3.81M |
|
|
1617
PUT
ProShares Ultra Silver
AGQ
$1.6B
| $8.69M | ﹤0.01% |
180,600
+4,000
| +2% | +$204K |
|
|
QEP
1618
PUT
DELISTED
QEP RESOURCES, INC.
QEP
| $8.66M | ﹤0.01% |
443,400
-32,300
| -7% | -$595K |
|
1619
Cameco
CCJ
$46.7B
| $8.63M | ﹤0.01% |
1,008,721
+286,177
| +40% | +$2.75M |
|
1620
CALL
Plains GP Holdings
PAGP
$5.57B
| $8.6M | ﹤0.01% |
249,418
+108,825
| +77% | +$3.28M |
|
|
PDCE
1621
PUT
DELISTED
PDC Energy, Inc.
PDCE
| $8.59M | ﹤0.01% |
128,100
+80,800
| +171% | +$4.89M |
|
1622
CALL
MGIC Investment
MTG
$6.42B
| $8.58M | ﹤0.01% |
1,073,000
+1,040,500
| +3,202% | +$7.74M |
|
1623
PUT
Cboe Global Markets
CBOE
$32.6B
| $8.58M | ﹤0.01% |
132,300
-157,100
| -54% | -$10.7M |
|
1624
PUT
Olin
OLN
$2B
| $8.56M | ﹤0.01% |
417,300
+35,600
| +9% | +$766K |
|
|
DO
1625
PUT
DELISTED
Diamond Offshore Drilling
DO
| $8.56M | ﹤0.01% |
486,100
+136,300
| +39% | +$2.73M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.